This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: Medskin Solutions Dr. Suwelack Ag, Other. Active years: 2015-2021.
Company Filing History:
1 out of 8 
1 out of 834,453 Years Active: 2015-2021
Title: Fabian Kuhlmann: Innovator in Biopolymer Production
Introduction
Fabian Kuhlmann is a notable inventor based in Rosendahl, Germany. He has made significant contributions to the field of biopolymers, holding a total of 2 patents. His work focuses on innovative methods for producing biopolymers and freeze-dried compositions of active substances.
Latest Patents
Kuhlmann's latest patents include "Methods for the production of biopolymers with defined average molecular weight." This invention relates to a method for producing a biopolymer with a defined average molecular weight, involving lyophilizing a composition that includes the biopolymer with native high molecular weight. The process is designed to facilitate controlled degradation of the biopolymer during sublimation. Another significant patent is for a "Freeze-dried composition of active substances." This invention covers freeze-dried molded articles containing at least 50% by weight of one or more active substances and up to 15% by weight of scaffold-forming agents, excluding proteins. The patent also details methods for manufacturing these articles and their applications in pharmaceutical and cosmetic fields.
Career Highlights
Throughout his career, Kuhlmann has worked with various companies, including Medskin Solutions Dr. Suwelack AG. His expertise in biopolymer production has positioned him as a key player in the industry, contributing to advancements in both pharmaceutical and cosmetic applications.
Collaborations
Kuhlmann has collaborated with notable professionals in his field, including Claudia Elsinghorst and Ralf Malessa. These collaborations have further enhanced his research and development efforts in biopolymer technologies.
Conclusion
Fabian Kuhlmann's innovative work in biopolymer production and active substance compositions showcases his commitment to advancing technology in the pharmaceutical and cosmetic industries. His contributions are significant and continue to impact the field positively.